AI Generated Image
Antidepressant duloxetine recalled over cancer risk
NBC New York • • business
Key Points:
- Breckenridge Pharmaceuticals is recalling specific lots of duloxetine delayed-release capsules due to high levels of the cancer-causing compound N-nitroso-duloxetine, exceeding FDA limits.
- The recall affects 30mg capsules with an expiration date of April 2027 (Lot 241180C) and two lots of 60mg capsules expiring in February 2026 (Lot 230286C) and February 2027 (Lot 24072lC).
- Duloxetine is a generic antidepressant used to treat depression, anxiety, and fibromyalgia.
- Patients with recalled medication are advised to consult their doctor or pharmacist before discontinuing use or seeking alternatives.
- The recall is based on testing reported by the FDA and California Board of Pharmacy, and the medication was distributed nationwide.
